$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The Plasma and Urinary Carnitine System in Korean Diabetic Patients 원문보기

Nutritional sciences, v.8 no.2, 2005년, pp.97 - 103  

Lee Yeoul (Department of Food Science and Nutrition and Research Institute of Human Ecology, Chonbuk National University) ,  Heo Young Ran (Department of Food and Nutrition, Collage of Human Ecology Chonnam National University) ,  Cha Youn Soo (Department of Food Science and Nutrition and Research Institute of Human Ecology, Chonbuk National University)

Abstract AI-Helper 아이콘AI-Helper

The goal of this study was to investigate abnotmalities in camitine metabolism present by determining blood camitine and lipid concentrations in Korean diabetic patients. The study subjects included 108 Korean diabetic patients (64 males and 44 females) who were hospitalized in Chonbuk National Univ...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

제안 방법

  • In this study, we measured carnitine and lipid profiles in the blood and urine from Korean diabetic patients and investigated the relationships between these two metabolic variables. We also compared these variables according to the criteria of diabetes defined by fasting and postprandial glucose levels that the American Diabetic Association suggests?
  • Diabetic patients with coronary heart disease, chronic renal failure, liver cirrhosis and severe nutritional deficiency were excluded. Patients were grouped into three groups; fasting hyperglycemia (FHG, 目 120 mg/dL), postprandial hyperglycemia (PHG, W 260 mg/dL) and overt hyperglycemia (OHG, FHG and PHG).

대상 데이터

  • The study subjects included 108 Korean diabetic patients (64 males and 44 females) who were hospitalized in Chonbuk National University Hospital and the 27 subjects were also hospitalized as non-diabetic controls (10 males and 17 females). Diabetic patients with coronary heart disease, chronic renal failure, liver cirrhosis and severe nutritional deficiency were excluded.

데이터처리

  • Values are mean±SD. Values with different superscripts are significantly different by ANOVA with Duncan's multiple range test at P<0.05.

이론/모형

  • , Seoul Korea). HDL-cholesterol was measured by the sedimentation enzymatic method and LDL-cholesterol was calculated by the Friedewald formula: total cholesterol -(triglyceride/5 + HDL-cholesterol).
  • Plasma total cholesterol (TC) levels were measured by using commercial kits (Asan Pharm. Co., Seoul, Korea) based on the cholesterol oxidase method. Serum triglyceride levels were measured by the lipase-glycerol phosphate method using commercial kits (Asan Pharm.
  • , Seoul, Korea) based on the cholesterol oxidase method. Serum triglyceride levels were measured by the lipase-glycerol phosphate method using commercial kits (Asan Pharm. Co., Seoul Korea). HDL-cholesterol was measured by the sedimentation enzymatic method and LDL-cholesterol was calculated by the Friedewald formula: total cholesterol -(triglyceride/5 + HDL-cholesterol).
  • , Seoul, Korea). The fasting plasma insulin (FPI) and postprandial plasma insulin (PPI) levels were measured by imniunoradiometric method (Pharmacia Corp., Uppsala, Sweden).
본문요약 정보가 도움이 되었나요?

참고문헌 (25)

  1. DeFronzo R, Bonadonna R, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992 

  2. DeFronzo R. Pathogenesis of type 2 diabetes; metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews 5:177-269, 1997 

  3. Weyer C, Bogardus C, Mott D, Pratley R. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999 

  4. American Diabetes association. Postprandial blood glucose. Diabetes Care 24:775-778, 2001 

  5. Matthai S, Stmvoll M, Kellerer M, Haring H. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21:585-618, 2000 

  6. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo R. The metabolic profile of NIDDM is fully established in glucosetolerant offsprings of two Mexican-American NIDDM parents. Diabetes 41:1575-1586, 1992 

  7. Lillioja S, Mott D, Howard B, Bennett P, Yki-Jarvinen H, Freymond D, Nyomba B, Zurlo F, Swinburn B, Bogardus C. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988 

  8. Martin B, Warram J, Krolewski A, Bergman R, Soeldner J, Kahn C. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992 

  9. Kendler B. Carnitine. An overview if its role in preventive medicine. Preventive Medicine 15:373-390, 1986 

  10. Rebouche C, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 8:39-61, 1998 

  11. Derosa G, Cicero A, Gaddi A, Mugellini A, Ciccarelli L, Fogari R. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 25:1429-1439, 2003 

  12. Brooks S, Bahl J, Bressler R. Carnitine in the streptozotocin-diabetic rat. J Nutr 115:1267-1273, 1985 

  13. Giancaaterini A, De Gaetano A, Mingrone G, Capristo E, Greco A. Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism 49:704-708, 2000 

  14. Lowitt S, Malone J, Salem A, Korthals J, Benford S. Acetyl L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 44:677-680, 1995 

  15. Heo Y, Lee Y, Cha Y. L-carnitine Administration Improves Lipid Metabolism in Streptozotocin-induced diabetic rat. Nutritional Science 5:3-8, 2002 

  16. Yoshikawa Y, Ueda E, Sahurai H, Kojima Y. Anti-diabetices effect of Zn(II)/carnitine complex by oral administration. Chem Pharm Bull 51:230-231, 2003 

  17. Reaven G. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988 

  18. Laakso M. Hyperglycemia and cardiovascular disease in Type 2 diabetes. Diabetes 48:937-942, 1999 

  19. Howard B. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987 

  20. Cavallero E, Dachet C, Neufcou D, Wirquin E, Mathe D, Jacotot B. Postprandial amplication of lipopotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagons levels. Metabolism 43:270-278, 1994 

  21. Niina M, Mikko S, Marja-riitta T. Postprandial lipid metabolism in diabetes. Atherosclerosis 141suppl:S53-S55, 1998 

  22. Bieber L. Carnitine. AnnRev Biochem 57:261-283, 1988 

  23. Bell F, Vidmar R, Raymond T. L-carnitine administration and withdrawal affect plasma and hepatic carnitine concentrations, plasma lipid and lipoprotein composition, and in vitro hepatic lipogenesis from labeled mevalonate and olate in normal rabits. J Nutr 122:959-966, 1992 

  24. Monola P, Belfiore A, Santangelo F, Senicchio M. L-Carnitine on the apolipoprotein pattern of rats fed a cholesterol-rich diet. Comp Biochem Physiol 89:69-73, 1988 

  25. Sachan D, Dodsan W. The serum carnitine status of cancer patients. J Am Nutr 6(2):14-15, 1987 

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로